< Back to previous page
Researcher
Frédéric Amant
- Disciplines:Gynaecology
Affiliations
- Gynaecological Oncology (Division)
Responsible
From1 Mar 2006 → Today - Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 61
- Overcoming resistance to anti-PD1 blockade in uterine leiomyosarcomasFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Post-mortem tissue biobanking to illuminate end-stage ovarian cancer disease (ATLASOvCANCER)From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Improving treatment of rare women’s cancers and conditions.From1 Oct 2023 → TodayFunding: BOF - ZAP BOF mandates
- Towards a better understanding of incidental cancer detection upon non-invasive prenatal testingFrom17 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Advisory Board Cancer Infertility Pregnancy (ABCIP)From1 Jan 2023 → 31 Dec 2023Funding: Other federal public and semi-governmental institutions
- ProPOSE: Proton therapy in Pregnancy for Optimal, Safe and Effective cancer treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Impact of prenatal exposure to cancer treatment during pregnancy and of chemotherapy for breast cancer on the brains: a multimodal MR imaging studyFrom1 Dec 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 584
- Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery(2022)
Authors: Frédéric Amant
Pages: 1611 - 1614 - The Advisory Board on Cancer, Infertility and Pregnancy: a virtual on-demand multidisciplinary tumour board(2022)
Authors: Frédéric Amant, Joosje Heimovaara, Kristel Van Calsteren
Pages: 1484 - 1486 - The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification(2022)
Authors: Frédéric Amant
Pages: 196 - 204 - Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?(2022)
Authors: Indra Van Assche, Jurgen Lemiere, Frédéric Amant, Kristel Van Calsteren
- The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma(2022)
Authors: Wout De Wispelaere, Frédéric Amant
- Less is more in gynaecological oncology: paving the way for the future(2022)
Authors: Frédéric Amant
Pages: 464 - 465 - Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer(2022)
Authors: Frédéric Amant
Pages: 466 - 472 - Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets(2022)
Authors: Huiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, Nathalie Brison, Kris Van Den Bogaert, Ruben Heremans, Agnieszka Wozniak, Christophe Dooms, Els Wauters, Sigrid Hatse, et al.
Pages: 1164 - 1176 - Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers(2022)
Authors: Ali Talebi, Wout De Wispelaere, Regina Esi Mensimah Baiden-Amissah, Guy Eelen, Emanuele Berardi, Johan Swinnen, Peter Carmeliet, Diether Lambrechts, Sarah-Maria Fendt, Daniela Annibali, et al.
- Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?(2022)
Authors: Frédéric Amant
Pages: 284 - 291